Investing Profile

Martin Münchbach

InvestorVC
Managing Partner at Pureos Bioventures
pureosbio.comZurich, Switzerland
Photo of Martin Münchbach, Managing Partner at Pureos Bioventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Pureos Bioventures Managing Partner
$100K - $5.0M
$1.5M
12
$205M
CompanyStageDateRound SizeTotal Raised
Ariceum Therapeutics
Series AApr 2023$25M
Series AJun 2022$27M
$52M
Co-investors: Per Samuelsson (HealthCap), Olivier Litzka (Andera Partners), Christoph Massner (Earlybird Venture Capital)
Radius Health
Private EquityApr 2013$43M
Private EquityDec 2011$21M
Series CJul 2011$66M
Series CNov 2008$15M
Series BApr 2007$58M
$200M
Co-investors: Elizabeth Stoner (MPM Capital), Ansbert Gadicke (MPM Capital), Zack Scott (Norwest Venture Partners)
Tioga Pharmaceuticals
Series UnknownFeb 2010$18M
Series AJan 2006$24M
$42M
Molecular Partners
Series BDec 2009$44M
Series AAug 2007$16M
$60M
BioVascular
Series CFeb 2008$11M
$11M